NRX101 Glx Biomarker Validation Study
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Bipolar Depression
- Suicidal Ideation
- Type
- Interventional
- Phase
- Phase 2Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Outcomes Assessor)Masking Description: Participants and Care Providers will be masked with regard to medication administered.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03402152
- Collaborators
- Target Health Inc.
- Investigators
- Principal Investigator: Joshua T Kantrowicz, MD New York State Psychiatric Institute